Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts

C. W. Putnam, R. H. Bell, R. W. Beart, J. T. Anderson, R. Weil IIIrd

Research output: Contribution to journalArticlepeer-review

Abstract

We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantion since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.

Original languageEnglish (US)
Pages (from-to)59-63
Number of pages5
JournalPostgraduate Medical Journal
Volume52
Issue numberSup.5
StatePublished - 1976
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts'. Together they form a unique fingerprint.

Cite this